PMID: 9438379Jan 23, 1998Paper

The CD38/cyclic ADP-ribose system: a topological paradox

The International Journal of Biochemistry & Cell Biology
A De FloraE Zocchi

Abstract

CD38 was first identified as a lymphocyte differentiation antigen that showed typical properties of an orphan receptor involved in many programs of cell proliferation and activation. However, CD38 proved also to be a bifunctional ectoenzyme that catalyzes the transient formation of cyclic ADP-ribose (cADPR) in a variety of cell types. This property raises many intriguing and so far unanswered questions, since cADPR is a new second messenger molecule directly involved in the control of calcium homeostasis by means of receptor-mediated release of calcium from ryanodine-sensitive intracellular stores. The relationship between receptor-like and enzymatic properties of CD38 is still unknown. The apparent topological paradox of ectocellular synthesis and intracellular activity of cADPR might be explained by: (a) influx of cADPR across the plasma membrane to reach its target stores, as suggested by experiments on cerebellar granule cells; and (b) NAD(+)-induced internalization, following membrane oligomerization, of CD38 with consequent partial import of cADPR metabolism to an intracellular compartment, as recently observed in lymphoid B cells. These two distinct mechanisms and other potential ones (e.g. binding of ectocellularly form...Continue Reading

References

Aug 1, 1992·Trends in Pharmacological Sciences·A Galione
Jan 1, 1992·International Journal of Clinical & Laboratory Research·F MalavasiS Roggero
Jan 15, 1986·The Biochemical Journal·J L Gordon
Mar 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·E L ReinherzS F Schlossman
Oct 1, 1995·Immunology Today·F LundM Howard
Apr 21, 1995·The Journal of Biological Chemistry·H C LeeR M Graeff
May 16, 1995·Biochemical and Biophysical Research Communications·V MészárosL G Mészáros
May 1, 1995·European Journal of Immunology·C M AusielloF Malavasi
Mar 1, 1995·The Journal of Experimental Medicine·M KumagaiD Campana
Sep 1, 1994·Molecular and Cellular Biochemistry·H C Lee
Nov 15, 1994·Biochemical and Biophysical Research Communications·H Muller-SteffnerF Schuber
Jan 1, 1994·Annual Review of Immunology·J C CambierM R Clark
Aug 15, 1994·Biochemical and Biophysical Research Communications·L FrancoA De Flora
Sep 15, 1994·Biochemical and Biophysical Research Communications·H NishinaT Katada
Mar 1, 1994·Immunology Today·F MalavasiK Mehta
Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·T KaishoT Hirano
Oct 22, 1993·Science·M S IslamP O Berggren
Dec 6, 1993·FEBS Letters·R J SummerhillA Galione
Jan 1, 1994·Advances in Immunology·M R Gold, A L DeFranco
Jan 28, 1993·Nature·M J Berridge
Aug 18, 1993·Biochimica Et Biophysica Acta·U H KimN H An
Sep 13, 1993·Biochimica Et Biophysica Acta·T F Walseth, H C Lee

❮ Previous
Next ❯

Citations

Apr 12, 2008·Purinergic Signalling·Silvia Deaglio, Fabio Malavasi
Jan 4, 2001·Leukemia Research·S DeaglioF Malavasi
Dec 6, 2001·The International Journal of Biochemistry & Cell Biology·Keng Meng Khoo, Chan Fong Chang
Jan 10, 2012·The Journal of Biological Chemistry·Dev ChuramaniLeslie Dale
Feb 22, 2012·Cold Spring Harbor Symposia on Quantitative Biology·C Cantó, J Auwerx
Nov 23, 2011·Pharmacological Reviews·Carles Cantó, Johan Auwerx
Sep 13, 2012·Science Signaling·Yong Juan ZhaoHon Cheung Lee
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·H C Lee
Mar 24, 2007·Molecular Medicine·Richard A BillingtonElena Zocchi
Jul 26, 2011·Science China. Life Sciences·Hon Cheung Lee
Jun 3, 2014·Pharmacology & Therapeutics·Violeta N Mutafova-Yambolieva, Leonie Durnin
Dec 24, 2014·Biochimica Et Biophysica Acta·Andreas H Guse
Dec 6, 2012·Toxicon : Official Journal of the International Society on Toxinology·Tsuyoshi NakanoYukari Totsuka
Jun 9, 2012·Acta Biochimica Et Biophysica Sinica·Yongjuan ZhaoHon Cheung Lee
Apr 15, 2010·Innate Immunity·Andreas GrahnertSunna Hauschildt
Nov 20, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Dae-Ryoung ParkUh-Hyun Kim
Jan 13, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·R A BillingtonA A Genazzani
Mar 5, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Li SunMone Zaidi
Oct 16, 1999·The Journal of Biological Chemistry·C MunshiH C Lee
May 20, 2000·The Journal of Biological Chemistry·K M KhooC F Chang
Mar 19, 2004·The Journal of Biological Chemistry·Lucrezia GuidaAntonio De Flora
Nov 7, 1998·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·L FrancoA De Flora
Oct 19, 2002·The Journal of Biological Chemistry·Cyrus B MunshiHon Cheung Lee
Jul 28, 2020·Cells·Anwesha KarShilpak Chatterjee
Feb 11, 1999·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·E ZocchiA De Flora
Oct 28, 2004·Journal of Endocrinological Investigation·A Antonelli, E Ferrannini
Jan 25, 2008·The Biochemical Journal·Sridhar R VasudevanGrant C Churchill
Nov 18, 2020·Nature Metabolism·Shuai Wu, Rugang Zhang
Nov 18, 2020·Nature Metabolism·Claudia C S ChiniEduardo N Chini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.